Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Invesco Dorsey Wright Momentum ETF stock logo
PDP
Invesco Dorsey Wright Momentum ETF
$109.09
+1.4%
$104.92
$86.41
$117.67
$1.68B1.0222,290 shs34,894 shs
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
$11.75
$11.78
$11.28
$11.95
$254.05M-0.01101,479 shs1 shs
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
$3.85
+0.8%
$4.51
$2.51
$2,592.00
$166K1.43175,870 shs3,420 shs
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$15.59
+2.3%
$14.07
$9.90
$27.20
$1.27B0.391.15 million shs396,663 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Invesco Dorsey Wright Momentum ETF stock logo
PDP
Invesco Dorsey Wright Momentum ETF
0.00%+1.27%+1.94%+20.54%+10.50%
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
0.00%0.00%0.00%-0.89%+4.17%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.00%+5.48%-10.26%+24.60%-99.81%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
0.00%+8.76%+6.16%+32.30%+26.50%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Invesco Dorsey Wright Momentum ETF stock logo
PDP
Invesco Dorsey Wright Momentum ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/AN/AN/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
1.7675 of 5 stars
4.50.00.00.02.10.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Invesco Dorsey Wright Momentum ETF stock logo
PDP
Invesco Dorsey Wright Momentum ETF
2.68
Moderate Buy$109.09N/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
0.00
N/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.00
N/AN/AN/A
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
2.90
Moderate Buy$37.56140.97% Upside

Current Analyst Ratings Breakdown

Latest UPC, VRDN, OBD, PDP, and RENE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$36.00 ➝ $36.00
5/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$31.00 ➝ $27.00
5/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$46.00 ➝ $45.00
5/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$42.00 ➝ $38.00
5/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$38.00 ➝ $36.00
4/23/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$34.00 ➝ $34.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Invesco Dorsey Wright Momentum ETF stock logo
PDP
Invesco Dorsey Wright Momentum ETF
N/AN/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/A$0.40 per share29.45($0.64) per shareN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
$23.02M0.01N/AN/A$163.50 per share0.02
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$300K4,238.60N/AN/A$6.09 per share2.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Invesco Dorsey Wright Momentum ETF stock logo
PDP
Invesco Dorsey Wright Momentum ETF
N/AN/A27.88N/AN/AN/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
$11.44MN/A0.00N/AN/A-51.08%5.43%8/13/2025 (Estimated)
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
-$6.16MN/A0.00N/AN/AN/AN/AN/A
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-$269.95M-$3.85N/AN/AN/A-102,092.39%-70.61%-44.67%8/14/2025 (Estimated)

Latest UPC, VRDN, OBD, PDP, and RENE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-$0.95-$0.87+$0.08-$0.87$0.16 million$0.07 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Invesco Dorsey Wright Momentum ETF stock logo
PDP
Invesco Dorsey Wright Momentum ETF
$0.220.20%N/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/AN/AN/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/AN/AN/A
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
N/AN/AN/AN/AN/A

Latest UPC, VRDN, OBD, PDP, and RENE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/23/2025
Invesco Dorsey Wright Momentum ETF stock logo
PDP
Invesco Dorsey Wright Momentum ETF
Quarterly$0.04290.16%6/23/20256/23/20256/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Invesco Dorsey Wright Momentum ETF stock logo
PDP
Invesco Dorsey Wright Momentum ETF
N/AN/AN/A
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
N/A
0.09
0.09
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/A
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
0.05
19.49
19.49
CompanyEmployeesShares OutstandingFree FloatOptionable
Invesco Dorsey Wright Momentum ETF stock logo
PDP
Invesco Dorsey Wright Momentum ETF
N/A15.40 millionN/AOptionable
Cartesian Growth Co. II stock logo
RENE
Cartesian Growth Co. II
221.62 million15.87 millionNot Optionable
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
22043,000731,000Not Optionable
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
5081.59 million81.06 millionOptionable

Recent News About These Companies

Viridian Therapeutics: The Song Remains The Same
Viridian Therapeutics appoints Ajer to its board of directors

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Invesco Dorsey Wright Momentum ETF stock logo

Invesco Dorsey Wright Momentum ETF NASDAQ:PDP

$109.09 +1.54 (+1.43%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PowerShares DWA Technical Leaders Portfolio (the Fund) is based on the Dorsey Wright Technical Leaders Index (the Index). The Fund seeks investment results that generally correspond to the price and yield of the Index. The Fund will normally invest at least 90% of its total assets in securities that consists of the Index and American Depositary Receipts (ADRs) based on the securities in the Index. The Index includes approximately 100 the United States-listed companies. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.

Cartesian Growth Co. II stock logo

Cartesian Growth Co. II NASDAQ:RENE

$11.75 0.00 (0.00%)
As of 05/13/2025

Cartesian Growth Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 13, 2021 and is headquartered in New York, NY.

Universe Pharmaceuticals stock logo

Universe Pharmaceuticals NYSE:UPC

$3.85 +0.03 (+0.79%)
Closing price 07/3/2025 03:17 PM Eastern
Extended Trading
$3.72 -0.13 (-3.35%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.

Viridian Therapeutics stock logo

Viridian Therapeutics NASDAQ:VRDN

$15.58 +0.36 (+2.33%)
Closing price 07/3/2025 01:39 PM Eastern
Extended Trading
$15.58 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.